» Articles » PMID: 22456585

Cognitive Impairments in Schizophrenia and Schizoaffective Disorder: Relationship with Clinical Characteristics

Overview
Journal J Nerv Ment Dis
Specialties Neurology
Psychiatry
Date 2012 Mar 30
PMID 22456585
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The present study aimed to compare population-based familial samples of patients with schizophrenia (n = 218) and schizoaffective disorder (n = 62) and a healthy control group (n = 123). Patients with schizoaffective disorder outperformed patients with schizophrenia in verbal ability, processing speed, visual working memory, and verbal memory. When compared with controls, patients with schizoaffective disorder also had a generalized cognitive impairment. Adjusting for clinical characteristics removed significant differences between the patient groups. Irrespective of the diagnosis, patients with the most severe negative symptoms and highest dose of antipsychotics had the most severe cognitive impairments, whereas mood symptoms were not related to cognitive performance. In conclusion, people with schizoaffective disorder have severe cognitive impairments, but the impairments are milder than in schizophrenia. Mood symptoms may not explain the difference between the diagnostic groups in cognitive functions, but the difference may be related to differences in the severity of negative symptoms.

Citing Articles

Correlations between Negative Symptoms and Cognitive Deficits in Individuals at First Psychotic Episode or at High Risk of Psychosis: A Systematic Review.

Melillo A, Caporusso E, Giordano G, Giuliani L, Pezzella P, Perrottelli A J Clin Med. 2023; 12(22).

PMID: 38002707 PMC: 10672428. DOI: 10.3390/jcm12227095.


A Digital System (YouXin) to Facilitate Self-Management by People With Psychosis in China: Protocol for a Nonrandomized Validity and Feasibility Study With a Mixed Methods Design.

Zhang X, Lewis S, Carter L, Bucci S JMIR Res Protoc. 2023; 12:e45170.

PMID: 37698905 PMC: 10523209. DOI: 10.2196/45170.


Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia.

Haddad C, Salameh P, Sacre H, Clement J, Calvet B BMC Psychiatry. 2023; 23(1):61.

PMID: 36694187 PMC: 9872384. DOI: 10.1186/s12888-023-04552-y.


Predictive Biomarkers for Antipsychotic Treatment Response in Early Phase of Schizophrenia: Multi-Omic Measures Linking Subcortical Covariant Network, Transcriptomic Signatures, and Peripheral Epigenetics.

Zong X, He C, Huang X, Xiao J, Li L, Li M Front Neurosci. 2022; 16:853186.

PMID: 35615285 PMC: 9125083. DOI: 10.3389/fnins.2022.853186.


Metacognitive Beliefs, Cognitive Functioning, Psychiatric Symptoms and Empathy in People with Schizophrenia.

Chuang S, Wu J, Wang C Neuropsychiatr Dis Treat. 2021; 17:2209-2217.

PMID: 34262281 PMC: 8274239. DOI: 10.2147/NDT.S313932.